Donald B. Kohn, M.D. is a Professor in the Departments of Microbiology, Immunology & Molecular Genetics and Pediatric (Hematology/Oncology) at UCLA. He is a board-certified pediatrician with >30 years of experience in clinical bone marrow transplantation. His principle area of research is the development and application of methods for gene therapy of blood cell diseases, such as Severe Combined Immune Deficiency and Sickle Cell Disease using autologous hematopoietic stem cells. His lab has investigated methods for optimal lentiviral vector-mediated gene delivery and expression and gene editing with human HSC, performing clinical trials of gene therapy for genetic diseases and pediatric HIV/AIDS. Dr. Kohn was the recipient of a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation (2000-2007), is a past-President of the American Society of Gene and Cell Therapy (2004) and of the Clinical Immunology Society (2014); and was a member (and Chair) of the NIH OBA RAC (2010-2015). He is a member of the ISCT Immuno-Gene Therapy Committee.